Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 November 2020 | Story Nonsidiso Qwabe | Photo Supplied

Acclaimed South African writer, author, and UFS research fellow Zubeida Jaffer was honoured with a lifetime achievement award for her career in journalism during the Standard Bank Sivukile Awards ceremony. 

Passion for journalism spans decades
During the award ceremony on 15 October 2020, Jaffer received the prestigious Allan Kirkland Soga Lifetime Achievement Award, which recognises a sustained and extraordinary contribution to journalism. Jaffer said she never chose journalism, but journalism chose her. She said when she first stepped into a newsroom looking for a holiday job in the 1970s, she did not know she had stepped into her future in news reporting. Since then, Jaffer has earned many accolades in the journalism industry as well as in academia. She also became an acclaimed author, and wrote her third book, Beauty of the Heart: The Life and Times of Charlotte Mannya Maxeke, during her time as a writer-in-residence at the UFS. While at the UFS, she founded the online media platform, The Journalist, a platform that provides history and context for key issues facing South African journalists. This portal also links students with academics across the country and will soon be extended to the African continent and the diaspora.

Jaffer said she felt blessed to be recognised among the many journalism pioneers in South Africa. 

“It’s extremely wonderful because it came so out of the blue. This year, with COVID-19, I was digging deep, and trying my best to keep focus. I’m very thankful. It’s made me pause, reflect, and realise that a lot of things I’ve done have been of value. When living your life, it’s not that you’re aware of that all the time. There are many people doing great things who don’t always get this kind of recognition,” Jaffer said.

Still a great need for journalists in South Africa 

Talking about journalism today, Jaffer said: “I am often overwhelmed to witness the enthusiasm and determination of young journalists across the country who come from humble backgrounds and inspire those around them. Our country is gripped in a bipolar condition. It is not clear how the healing will come, but it will. The challenge is to keep our minds in balance so that we can be strong enough to root out corruption and gender-based violence, while at the same time fully understanding our blessings as a people.”

UFS alumna Rising Star in Journalism 

In another accolade for the UFS, the Upcoming/Rising Star of the Year award went to former UFS Journalism student Brümilda Swartbooi for her article titled ‘Sy het hard vir ons gewerk’. The article highlighted the senseless killing of a woman outside her workplace, minutes after her husband dropped her off.

Brümilda Swartbooi. Photo: Supplied

News Archive

Stem cell research and human cloning: legal and ethical focal points
2004-07-29

   

(Summary of the inaugural lecture of Prof Hennie Oosthuizen, from the Department of Criminal and Medical Law at the Faculty of Law of the University of the Free State.)

 

In the light of stem cell research, research on embryo’s and human cloning it will be fatal for legal advisors and researchers in South Africa to ignore the benefits that new bio-medical development, through research, contain for this country.

Legal advisors across the world have various views on stem cell research and human cloning. In the USA there is no legislation that regulates stem cell research but a number of States adopted legislation that approves stem cell research. The British Parlement gave permission for research on embryonic stem cells, but determined that it must be monitored closely and the European Union is of the opinion that it will open a door for race purification and commercial exploitation of human beings.

In South Africa the Bill on National Health makes provision for therapeutical and non therapeutical research. It also makes provision for therapeutical embryonical stem cell research on fetuses, which is not older than 14 days, as well as for therapeutical cloning under certain circumstances subject to the approval of the Minister. The Bill prohibits reproductive cloning.

Research on human embrio’s is a very controversial issue, here and in the rest of the world.

Researchers believe that the use of stem cell therapy could help to side-step the rejection of newly transplanted organs and tissue and if a bank for stem cell could be built, the shortage of organs for transplants would become something of the past. Stem cells could also be used for healing of Alzheimer’s, Parkinson’s and spinal injuries.

Sources from which stem cells are obtained could also lead to further ethical issues. Stem cells are harvested from mature human cells and embryonic stem cells. Another source to be utilised is to take egg cells from the ovaries of aborted fetuses. This will be morally unacceptable for those against abortions. Linking a financial incentive to that could become more of a controversial issue because the woman’s decision to abort could be influenced. The ideal would be to rather use human fetus tissue from spontaneous abortions or extra-uterine pregnancies than induced abortions.

The potential to obtain stem cells from the blood of the umbilical cord, bone-marrow and fetus tissue and for these cells to arrange themselves is known for quite some time. Blood from the umbilical cord contains many stem cells, which is the origin of the body’s immune and blood system. It is beneficial to bank the blood of a newborn baby’s umbilical cord. Through stem cell transplants the baby or another family member’s life could be saved from future illnesses such as anemia, leukemia and metabolic storing disabilities as well as certain generic immuno disabilities.

The possibility to withdraw stem cells from human embrio’s and to grow them is more useable because it has more treatment possibilities.

With the birth of Dolly the sheep, communities strongly expressed their concern about the possibility that a new cloning technique such as the replacement of the core of a cell will be used in human reproduction. Embryonic splitting and core replacement are two well known techniques that are associated with the cloning process.

I differentiate between reproductive cloning – to create a cloned human embryo with the aim to bring about a pregnancy of a child that is identical to another individual – and therapeutically cloning – to create a cloned human embryo for research purposes and for healing human illnesses.

Worldwide people are debating whether to proceed with therapeutical cloning. There are people for and against it. The biggest ethical objection against therapeutical cloning is the termination of the development of a potential human being.

Children born from cloning will differ from each other. Factors such as the uterus environment and the environment in which the child is growing up will play a role. Cloning create unique children that will grow up to be unique individuals, just like me and you that will develop into a person, just like you and me. If we understand this scientific fact, most arguments against human cloning will disappear.

Infertility can be treated through in vitro conception. This process does not work for everyone. For some cloning is a revolutionary treatment method because it is the only method that does not require patients to produce sperm and egg cells. The same arguments that were used against in vitro conception in the past are now being used against cloning. It is years later and in vitro cloning is generally applied and accepted by society. I am of the opinion that the same will happen with regard to human cloning.

There is an argument that cloning must be prohibited because it is unsafe. Distorted ideas in this regard were proven wrong. Are these distorted ideas justified to question the safety of cloning and the cloning process you may ask. The answer, according to me, is a definite no. Human cloning does have many advantages. That includes assistance with infertility, prevention of Down Syndrome and recovery from leukemia.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept